Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00881 | Azido-PEG3-acid | 1056024-94-2 |
| Azido-PEG3-acid is a PEG-based PROTAC linker used in the synthesis of PROTACs. It is also a non-cleavable 3 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01490 | [(2-methylpropan-2-yl)oxycarbonylamino] 4-methylbenzenesulfonate | 105838-14-0 |
| N-Boc-O-tosyl hydroxylamine is used as a linker for antibody-drug conjugates (ADC). | Inquiry | |
| BADC-00886 | N-Hydroxysulfosuccinimide sodium | 106627-54-7 |
| N-Hydroxysulfosuccinimide (sodium) is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00890 | mPEG4-bromide | 110429-45-3 |
| mPEG4-bromide is a PEG linker containing a bromide group. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The hydrophilic PEG spacer increases solubility in aqueous media. | Inquiry | |
| BADC-01339 | AEEA-AEEA | 1143516-05-5 |
| 17-Amino-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecanoic acid is a complex organic molecule characterized by multiple functional groups and heteroatoms within its structure. It contains an amino group (-NH2) at the 17th position, a ketone group (oxo) at the 10th position, and several ether linkages (tetraoxa) throughout its carbon chain. Additionally, it features an amide linkage (aza) at the 9th position, which integrates nitrogen into the backbone. This compound is significant in biochemical and pharmaceutical research due to its potential applications in the design and synthesis of novel molecules with specific biological activities. | Inquiry | |
| BADC-01705 | N3-L-Val-OH (CHA) | 1217462-63-9 |
| N3-L-Val-OH (CHA) is a click chemistry containing an azide group, a valine derivative. | Inquiry | |
| BADC-00908 | DBCO-amine | 1255942-06-3 |
| Inquiry | ||
| BADC-00911 | Azido-PEG4-propionic acid | 1257063-35-6 |
| Azido-PEG4-acid is a PEG-based PROTAC linker used in the synthesis of PROTACs. It is also a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00912 | t-Boc-N-amido-PEG1-propionic acid | 1260092-44-1 |
| t-Boc-N-amido-PEG1-propionic acid is a cleavable (1-unit PEG) ADC linker, as well as a PEG- and alkyl/ether-based PROTAC linker that can be used to synthesize antibody-drug conjugates (ADCs) or PROTACs. | Inquiry | |
| BADC-00913 | Bis-PEG9-acid | 1268488-70-5 |
| Bis-PEG9-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Bis-PEG9-acid is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01668 | 1-Cbz-3-Hydroxyazetidine | 128117-22-6 |
| 1-Cbz-3-Hydroxyazetidine is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
| BADC-00915 | Amino-PEG6-t-butyl ester | 1286281-32-0 |
| NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00917 | Amino-PEG10-alcohol | 129449-09-8 |
| Amino-PEG10-OH is non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00923 | Azido-PEG7-amine | 1333154-77-0 |
| Azido-PEG7-amine is a non-cleavable 7 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00584 | Mal-amido-PEG8-acid | 1334177-86-4 |
| Mal-amido-PEG8-acid is a PEG derivative containing a maleimide group and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. The maleimide group will react with a thiol group to form a covalent bond, enabling the connection of biomolecule with a thiol. | Inquiry | |
| BADC-00926 | Hydroxy-PEG2-t-butyl ester | 133803-81-3 |
| Hydroxy-PEG2-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG2-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 196). | Inquiry | |
| BADC-00932 | DBCO-acid | 1353016-70-2 |
| Inquiry | ||
| BADC-01577 | N-Boc-amino-PEG3-acid | 1365655-91-9 |
| N-Boc-amino-PEG3-acid is a PEG derivative containing a terminal carboxylic acid and Boc-protected amino group. | Inquiry | |
| BADC-00938 | mPEG10-amine | 1383658-09-0 |
| m-PEG10-amine is a non-cleavable 10 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG10-amine is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. | Inquiry | |
| BADC-00940 | Br-PEG4-NHBoc | 1392499-32-9 |
| Br-PEG4-NHBoc is a PEG linker containing a bromide group and a Boc-protected amino group. The hydrophilic PEG spacer increases solubility in aqueous media. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The Boc group can be deprotected under mild acidic conditions to form the free amine. | Inquiry |
